This topic contains a solution. Click here to go to the answer

Author Question: According to Bandura, which of the following is NOT a core feature of human agency? a. ... (Read 68 times)

anjilletteb

  • Hero Member
  • *****
  • Posts: 569
According to Bandura, which of the following is NOT a core feature of human agency?
 
  a. intentionality
  b. forethought
  c. self-reactiveness
  d. self-determination

Question 2

According to Bandura, the idea that capacity to exercise control over the nature and quality of one's life is called:
 
  a. personal causation
  b. competence
  c. reciprocal determinism
  d. human agency



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ntsoane kedibone

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

d

Answer to Question 2

d




anjilletteb

  • Member
  • Posts: 569
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


softEldritch

  • Member
  • Posts: 334
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library